Sanofi Consumer Healthcare India credit ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Dec 2025FY25Dec 2024
−375−375−327
−0.98×−0.98×−1.20×
−1.02×−1.21×−1.21×
148.65×148.65×68.23×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SANOFICONR₹3,468.00

Sanofi Consumer Healthcare India Limited

· Pharma & Health
₹ CrorePeersPGHLSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹7,976 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY25
31/12/2024
FY26
31/12/2025
Last 12M
30/09/2026
Net Debt-326.9-375.2-375.2
Net Debt/Equity-1.20-0.98-0.98
Net Debt/EBITDA-1.21-1.21-1.02
Interest Coverage (EBIT/Interest)68.23148.65148.65
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.